Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy

Neurology

Volumn 64, Issue 9, 2005, Pages 1632-1634

  Lopate, G ^a   Pestronk, A ^a   Evans, S ^b   Li, L ^b   Clifford, D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI SULFATIDE ANTIBODY; ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYCLONAL ANTIBODY; RECOMBINANT NERVE GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SENSORY NEUROPATHY; SKIN BIOPSY;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; NEURALGIA; PARESTHESIA; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; SULFOGLYCOSPHINGOLIPIDS;

EID: 18144371640     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000160394.77818.AD     Document Type: Article

References (11)

1. Lopate G, Parks BJ, Goldstein JM, Yee WC, Friesenhahn GM, Pestronk A. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry 1997;62:581-585.
2. van den Berg LH, Lankamp CL, de Jager AE, et al. Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993;56:1164-1168.
3. De Gasperi R, Gama Sosa MA, Patarca R, et al. Intrathecal synthesis of anti-Sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome. AIDS Res Hum Retroviruses 1996;12:205-211.
4. Petratos S, Turnbull VJ, Papadopoulos R, Ayers M, Gonzales MF. High titre anti-sulphatide antibodies in HIV infected individuals. Neuroreport 1999;10:2557-2562.
5. So Y, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol 1988;45:945-948.
6. Seddiki N, Ben Younes-Chennoufi A, Benjouad A, et al. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages. AIDS Res Hum Retroviruses 1996;12:695-703.
7. van den Berg LH, Sadiq SA, Lederman S, Latov N. The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein. J Neurosci Res 1992;33:513-518.
8. McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 2000;54:1080-1088.
9. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmunity Rev 2002;1:329-337.
10. Nguyen DH, Hildreth JEK. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000;74:3264-3272. Stroke 2002;33:1584-1588.
11. Nguyen DH, Hildreth JEK. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000;74:3264-3272. Stroke 2002;33:1584-1588.